Details for Patent: 10,208,299
Which drugs does patent 10,208,299 protect, and when does it expire?
Patent 10,208,299 protects OPFOLDA and is included in one NDA.
This patent has ninety-five patent family members in forty-three countries.
Summary for Patent: 10,208,299
| Title: | Highly potent acid alpha-glucosidase with enhanced carbohydrates |
| Abstract: | Recombinant human alpha glucosidase (rhGAA) composition derived from CHO cells that contains a more optimized glycan composition consisting of a higher amount of rhGAA containing N-glycans carrying mannose-6-phosphate (M6P) or bis-M6P than conventional rhGAAs, along with low amount of non-phosphorylated high mannose glycans, and low amount of terminal galactose on complex oligosaccharides. Compositions containing the rhGAA, and methods of use are described. |
| Inventor(s): | Russell Gotschall, Hung V. Do |
| Assignee: | Amicus Therapeutics Inc |
| Application Number: | US15/515,808 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,208,299
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therap Us | OPFOLDA | miglustat | CAPSULE;ORAL | 215211-001 | Sep 28, 2023 | RX | Yes | Yes | 10,208,299 | ⤷ Start Trial | Y | Y | THE TREATMENT OF POMPE PATIENTS | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,208,299
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3201320 | ⤷ Start Trial | 301267 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3201320 | ⤷ Start Trial | LUC00336 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 3201320 | ⤷ Start Trial | CA 2024 00012 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
